| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Z614936-5mg |
5mg |
期货  |
| |
| Z614936-25mg |
25mg |
期货 |
|
| 别名 | 扎贝多塞蒂布 |
|---|---|
| 英文别名 | 1931994-81-8 | EX-A5143 | US10308634, Example 12 | HY-139374 | N-{6-(2-Hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide | UNII-N1GRK350ZM | N1GRK350ZM | Zabedosertib [INN] | SB74225 | BDBM395297 | |
| 规格或纯度 | Moligand™, ≥97% |
| 英文名称 | zabedosertib |
| 作用类型 | 抑制剂 |
| 作用机制 | 白细胞介素 1 受体相关激酶 4 抑制剂 |
| 纯度 | ≥97% |
| IIUPAC Name | N-[6-(2-hydroxypropan-2-yl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide |
|---|---|
| INCHI | 1S/C20H21F3N4O4S/c1-19(2,29)13-10-15-12(11-27(26-15)7-8-32(3,30)31)9-16(13)25-18(28)14-5-4-6-17(24-14)20(21,22)23/h4-6,9-11,29H,7-8H2,1-3H3,(H,25,28) |
| InChi Key | OQAMEEFUUFJZRS-UHFFFAOYSA-N |
| Smiles | CC(C)(C1=CC2=NN(C=C2C=C1NC(=O)C3=NC(=CC=C3)C(F)(F)F)CCS(=O)(=O)C)O |
| Isomeric SMILES | CC(C)(C1=CC2=NN(C=C2C=C1NC(=O)C3=NC(=CC=C3)C(F)(F)F)CCS(=O)(=O)C)O |
| 关联CAS | 1931994-81-8 |
| PubChem CID | 121364961 |
| MeSH Entry Terms | BAY-1834845;BAY1834845;N-(6-(1-hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;zabedosertib |
| 分子量 | 470.46 |
| 分子量 | 470.500 g/mol |
|---|---|
| XLogP3 | 2.200 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 9 |
| 可旋转键计数Rotatable Bond Count | 6 |
| 精确质量Exact Mass | 470.124 Da |
| 单同位素质量Monoisotopic Mass | 470.124 Da |
| 拓扑极表面积Topological Polar Surface Area | 123.000 Ų |
| 重原子数Heavy Atom Count | 32 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 787.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
首页
400-620-6333
